Search Results
Found 1 results
510(k) Data Aggregation
(145 days)
Hemos!L RecombiPlasTin 2G is a high sensitivity thromboplastin reagent based on recombinant human tissue factor (RTF) for the quantitative determination in human citrated plasma of Prothrombin Time (PT) and Fibringgen on IL Coagulation Systems. The product is used for the evaluation of the extrinsic coagulation pathway and the monitoring of Oral Anticoagulant Therapy (OAT).
Not Found
I am sorry, but the provided text does not contain the acceptance criteria or a study proving the device meets those criteria. The text is an FDA 510(k) clearance letter for the HemosIL RecombiPlasTin 2G device, stating its substantial equivalence to a predicate device and outlining regulatory information. It does not include details about device performance metrics, study designs, sample sizes, or ground truth establishment.
To answer your request, I would need a document that specifically details the performance evaluation of the HemosIL RecombiPlasTin 2G, including its acceptance criteria and the results of a study.
Ask a specific question about this device
Page 1 of 1